 |
|  | FDA APPROVES VISUDYNE FOR MYOPIA/OCULAR HISTOPLASMOSIS. : An article from: Biotech Business $5.95 | |
| FDA Clears First Tx for Wet Macular Degeneration. : An article from: Family Practice News $5.95 | |
|
|
|
Visudyne covered in Canada
GOOD NEWS FOR AMD PATIENTS * Health and Long-Term Care Minister Tony Clement announced last month that Ontario will provide more than $20 million in funding for the treatment of wet age-related macu
From Optometric Management,
6/1/02
| |
|
|
Panel gives thumbs up to Visudyne therapy for wet AMD - Ophthalmic Drugs Subcommittee of the Food and Drug Administration, age-related macular degeneration
The Ophthalmic Drugs Subcommittee of the FDA recommended approval of Visudyne therapy for the treatment of wet age-related macular degeneration, the leading cause of blindness among people over age
From Drug Store News,
12/13/99
| |
|
|
AMD therapy: Visudyne is a promising treatment
Tisudyne is a promising treatment You may soon have another weapon in your arsenal for fighting that toughest of opponents, age-related macular degeneration ...
From Optometric Management,
2/1/99
| |
|
|
PATHOLOGIC MYOPIA
Demographics * Age range at presentation: 50 years and older * Gender trends: None * Racial trends: None * Refractive error trends: High myopia * Associated ...
From Optometric Management,
9/1/05
by Angelilli, Allison
| |
|
|
INFLAMMATORY CHORIORETINAL DISEASE
Multifocal Choroiditis (MC) Multifocal choroiditis usually affects women in their 40s. Patients present with metamorphopsia or bilateral, subacute decrease ...
From Optometric Management,
9/1/05
by Angelilli, Allison
| |
|
|
CENTRAL SEROUS CHORIORETINOPATHY (CSC)
Demographics * Age range at presentation: Young to middle-aged * Gender trends: Increased prevalence in men * Racial trends: Increased incidence in Asian ...
From Optometric Management,
9/1/05
by Angelilli, Allison
| |
|
|
UPDATE: What's new in THERAPEUTICS
Emerging treatments for this widespread condition may prove useful for generations to come. Age-related macular degeneration (AMD) will be a major public ...
From Optometric Management,
7/1/05
by Semes, Leo
| |
|
|
Excerpts from: on the take
IN THIS ARTICLE ...
From Physician Executive,
3/1/05
by Jerome P. Kassirer
| |
|
Home
A
Hydrocodone